A multi-center crossover study of MQX-503, a topical formulation of nitroglycerin, in patients with Raynaud's phenomenon Denton, C. P., Fiorentino, D., Herrick, A., Sule, S., Rothfield, N., Belch, J., Shapiro, L., Scheja, A., Shanahan, J., Steen, V., Emery, P., Chung, L., Gregory, J., Batson, E., Dooley, T., Gilbert, A., Dechow, F., Wigley, F. M. WILEY-LISS. 2007: 4238

View details for Web of Science ID 000251781200057